Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Invited Review Article

PCSK9 Inhibitors in Secondary Prevention—An Opportunity for Personalized Therapy

Board, Chase PharmD*; Kelly, Michael S. PharmD; Shapiro, Michael D. DO, MCR; Dixon, Dave L. PharmD*

Author Information
Journal of Cardiovascular Pharmacology: May 2020 - Volume 75 - Issue 5 - p 410-420
doi: 10.1097/FJC.0000000000000809
  • Buy

Abstract

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.